Streptococcus salivarius K12: what this strain actually does

Updated August 29, 2026 · Every study cited below links to its PubMed record.

K12, sold under the trademark BLIS K12, is the most-studied oral probiotic strain in the world. The evidence is real for bad breath, promising but weaker for sore throat prevention, and frequently exaggerated by products borrowing claims that belong to its sibling strain M18. Here is what K12 has actually shown.

What is S. salivarius K12?

S. salivarius is one of the most numerous native bacteria in a healthy human mouth and among the first species babies acquire. K12 is a particular strain of it, isolated from the mouth of a healthy New Zealand child, chosen because it produces two bacteriocins, salivaricin A2 and salivaricin B: protein weapons that suppress competing bacteria, including species that produce breath odor and Streptococcus pyogenes, the strep-throat pathogen [3].

"BLIS" stands for bacteriocin-like inhibitory substances. It is a trademark of Blis Technologies, the company commercializing the strain, which is why the same K12 shows up in many different brands' lozenges.

Does K12 help bad breath?

This is its best-supported use. In the key trial, 23 adults with halitosis rinsed with chlorhexidine and then took K12 lozenges: at one week, 85% of the K12 group held substantial reductions in volatile sulfur compounds versus 30% on placebo [1]. Lab work backs the mechanism: K12 directly suppresses odor-producing species like Solobacterium moorei [2].

Note the trial design detail: the mouth was cleaned first, then K12 moved into the vacated territory. Taking it after thorough brushing copies that logic at home.

Does K12 prevent sore throats?

The signal is interesting and the caveats are large. In the most-cited study, 48 children with recurrent strep throat took K12 daily for 90 days and showed about a 90% reduction in streptococcal pharyngeal disease compared with their previous year, plus fewer viral infections than a comparison group [3].

The caveats: it was small, not randomized, the comparison group was healthier to begin with, and the lead author formulates the commercial product being tested. Treat throat prevention as plausible and low-risk rather than proven. If your kid gets strep three times a winter, it is a reasonable experiment to run alongside, never instead of, your pediatrician's plan.

K12 or M18: which one do you want?

They are sibling strains of the same species with different jobs, and products routinely blur them:

Breath or throat: K12. Plaque: M18. Both concerns: combination products carry the two together.

Is K12 safe?

Its species is a normal, dominant resident of healthy mouths, and K12's trial record, including 90-day daily use in children, reports no significant adverse events [3] [4]. The standing exception for all live supplements: ask a clinician first if immunocompromised or recovering from oral surgery.

How do you take K12?

As a lozenge, dissolved slowly, once daily after brushing at night, at 1 to 3 billion CFU depending on product. Expect breath changes within 1 to 4 weeks and plan on ongoing use; colonization fades within weeks of stopping. Two honestly labeled options we do not earn anything on: NOW OralBiotic (pure K12, 1 billion CFU per serving) and Hyperbiotics PRO-Dental (K12 plus M18, 3 billion CFU). Our overall bad-breath pick uses a different species entirely; see the full comparison.

New to the category? Start with the pillar guide: Oral probiotics: which strains work, and what to expect.